Pathway-focused metabolite ratio-based analysis of 49 tumor and 8 normal epithelial cell lines grown in their respective ...

When we consume foods containing sugar and starch, they are converted into energy in the body's cells through a process ...

At ASCO, researchers presented results of Phase I trials evaluating combinations of KRAS G12C inhibitors, EGFR inhibitors, and chemotherapy in colorectal cancer.

Losing the Y chromosome seems to make cancer cells more aggressive in men and the phenomenon may even spread between cells.

Darolutamide (Nubeqa) is granted FDA approval for metastatic castration-sensitive prostate cancer, enhancing survival and ...

After FDA approval in late 2023, the non-invasive liver tumor treatment histotripsy has been used at University of Michigan ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

Inflammation fuels the high rate of cancer in people over 50, researchers find, leading them to test anti-inflammatories like ...

Metabolic reprogramming is now recognized as a hallmark of cancer, playing a pivotal role in tumor progression, therapeutic resistance, immune evasion, and ...